4.6 Article

Risk tables for parkinsonism and Parkinson's disease

Journal

JOURNAL OF CLINICAL EPIDEMIOLOGY
Volume 55, Issue 1, Pages 25-31

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/S0895-4356(01)00425-5

Keywords

parkinsonism; Parkinson's disease; epidemiology; lifetime risk; cumulative risk; competing risks

Funding

  1. NIAMS NIH HHS [AR30582] Funding Source: Medline
  2. NINDS NIH HHS [NS33978] Funding Source: Medline
  3. NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR030582] Funding Source: NIH RePORTER
  4. NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033978] Funding Source: NIH RePORTER

Ask authors/readers for more resources

We applied the incidence rates of parkinsonism and Parkinson's disease (PD) from Olmsted County, MN (1976-1990) to a hypothetical cohort undergoing the mortality rates observed in Minnesota, and computed the lifetime risk and the remaining lifetime risk of developing parkinsonism and PD. These risks were compared to cumulative incidences that do not take competing risks of death into account. The lifetime risk of developing parkinsonism from birth was 4.4% for men and 3.7% for women (ratio = 1.2). The corresponding risk of developing PD was 2.0% for men and 1.3% for women (ratio = 1.5). Because of the opposite effect of higher incidence and higher mortality rates in men, the lifetime risks were only slightly higher in men than in women. Lifetime cumulative incidences were consistently higher than lifetime risks; this difference was more pronounced in men and in older subjects. Lifetime risk estimates are useful in clinical practice, epidemiologic research, and public health. (C) 2002 Elsevier Science Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available